IMRX
Immuneering Corp
4.60$
+3.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -231.4% | -632.5% | -1,483.2% | -13,914.2% | -10,762,337.1% | – | – | |
| 0.9% | 3.4% | 7.6% | 87.5% | 77,380.9% | – | – | |
| 31.1% | 47.0% | 86.7% | 1,282.4% | 1,258,711.0% | – | – | |
| 146.5% | 47.0% | 71.9% | 1,284.0% | – | – | – | |
| 22.8% | 54.2% | 43.3% | 541.8% | -214,206.8% | – | – | |
| 1.1% | 2.3% | 2.9% | 234.3% | 75,328.8% | – | – | |
| -1.1% | -2.3% | -3,635.5% | 13,197.9% | 1,603,624.6% | – | – | |
| – | – | 6,935.9% | 6.0% | – | – | – | |
| 199.2% | – | – | – | – | – | – | |
| 894.5% | 1,643.2% | 6,935.9% | 6.0% | 6,250,785.3% | – | – | |
| 662.0% | 1,008.3% | 1,817.2% | -710.3% | -2,907,927.3% | – | – | |
| -232.5% | -634.8% | -1,486.2% | -14,148.4% | -10,837,665.9% | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.